Asosiy kontentga oʻtish
Maqola

Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study

for the CORONADO investigatorsl'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, FranceMatthieu WargnyHôpital Bichat-Claude-BernardLouis PotierHôpital Bichat-Claude-BernardPierre GourdyInstitut des Maladies Métaboliques et Cardiovasculaires, UMR1048 Inserm/UPS, Université de Toulouse, Toulouse, FranceMatthieu Pichelinl'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, FranceCoralie AmadouUniversité Paris-Saclay, Paris, FrancePierre‐Yves BenhamouService Endocrinologie-Diabétologie-Nutrition, CHU Grenoble, Grenoble, FranceJean‐Baptiste BonnetDépartement de Diabétologie, H.I.A. Begin, Saint Mandé, FranceL. BordierCentre de Recherche des Cordeliers, Inserm, U-1138, Paris, FranceOlivier BourronFondation pour l’innovation en Cadiométabolisme et NutritionClaude ChaumeilUniversité Côte d'Azur, CHU, Inserm U1065, C3M, Nice, FranceNicolas ChevalierC2VN, Inserm, INRA, Aix Marseille Université, Marseille, FrancePatrice DarmonCentre Hospitalier Intercommunal Aix-PertuisB. DelenneService d'Endocrinologie, Diabétologie et Maladies Métaboliques, Centre Hospitalier d'Aix-en-Provence, Aix-en-Provence, FranceDelphine DemarsyService Endocrinologie-Diabétologie, Centre Hospitalier de la Côte Basque, Bayonne, FranceMarie DumasService Endocrinologie-Diabétologie, Hôpital Saint Vincent de Paul Lille, Lille, FranceO. DupuyService de Diabétologie Endocrinologie, Hôpital Paris Saint-Joseph, Paris, FranceAnna Flaus-FurmaniukCentre de Recherche des Cordeliers, Inserm, U-1138, Université de Paris, Paris, FranceJean–François GautierService de Diabétologie et d'Endocrinologie, Hôpital Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, FranceA.M. GuedjUniversité de NîmesN. JeandidierService de Diabétologie et Immunologie Clinique, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Centre-Université de Paris, Paris, FranceÉtienne LargerMédipole GaronneJean-Philippe Le BerreService de Diabétologie et d'Endocrinologie, Médipôle, Villeurbanne, FranceMyriam LungoService d'Endocrinologie et de Diabétologie, Centre Hospitalier de Bastia, Bastia, FranceNathanaëlle MontanierHôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Inserm UMR 1060 Carmen, Université Claude Bernard Lyon 1, Lyon, FrancePhilippe MoulinHôpital Cardiovasculaire Louis Pradel, Hospices Civils de Lyon, Inserm UMR 1060 Carmen, Université Claude Bernard Lyon 1, Lyon, FranceF. PlatService d'Endocrinologie et Maladies Métaboliques, Centre Hospitalier d'Avignon, Avignon, FranceVincent RigalleauUniversité de PoitiersRené RobertService de Diabétologie, Endocrinologie et Nutrition, Centre Hospitalier de Gonesse, Gonesse, FranceDominique Seret‐BéguéService de Diabétologie, Endocrinologie et Nutrition, Centre Hospitalier de Gonesse, Gonesse, FrancePierre Sérusclatl'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, FranceSarra SmatiInstitut du ThoraxJean-François ThébautInstitut des Maladies Métaboliques et Cardiovasculaires, UMR1048 Inserm/UPS, Université de Toulouse, Toulouse, FranceBlandine TramuntAssistance Publique – Hôpitaux de ParisCamille VatierCentre Hospitalier Universitaire Pointe-à-PitreFritz-Line VélayoudomService d'Endocrinologie, Diabétologie et Métabolisme, Centre Hospitalier Universitaire de Guadeloupe, Pointe-à-Pitre, FranceBruno VergèsService Endocrinologie, Diabétologie et Maladies Métaboliques, Hôpital du Bocage, Dijon, FrancePatrice WiniszewskiService d'Endocrinologie et Diabétologie, CHU de Martinique, Fort-de-France, FranceAudrey ZabulonService d'Endocrinologie et Diabétologie, CHU de Martinique, Fort-de-France, FrancePierre‐Antoine GourraudDépartement d'Endocrinologie, Diabétologie et Nutrition, Hôpital Bichat, Assistance Publique Hôpitaux de Paris, Paris, FranceRonan RousselCentre de Recherche des CordeliersBertrand Carioul'institut du thorax, Inserm, CNRS, UNIV Nantes, CHU Nantes, Nantes, France. [email protected]Samy HadjadjInstitut du Thorax
2021en
ABI

Annotatsiya

AIMS/HYPOTHESIS: This is an update of the results from the previous report of the CORONADO (Coronavirus SARS-CoV-2 and Diabetes Outcomes) study, which aims to describe the outcomes and prognostic factors in patients with diabetes hospitalised for coronavirus disease-2019 (COVID-19). METHODS: The CORONADO initiative is a French nationwide multicentre study of patients with diabetes hospitalised for COVID-19 with a 28-day follow-up. The patients were screened after hospital admission from 10 March to 10 April 2020. We mainly focused on hospital discharge and death within 28 days. RESULTS: . Microvascular and macrovascular diabetic complications were found in 44.2% and 38.6% of participants, respectively. Within 28 days, 1404 (50.2%; 95% CI 48.3%, 52.1%) were discharged from hospital with a median duration of hospital stay of 9 (5-14) days, while 577 participants died (20.6%; 95% CI 19.2%, 22.2%). In multivariable models, younger age, routine metformin therapy and longer symptom duration on admission were positively associated with discharge. History of microvascular complications, anticoagulant routine therapy, dyspnoea on admission, and higher aspartate aminotransferase, white cell count and C-reactive protein levels were associated with a reduced chance of discharge. Factors associated with death within 28 days mirrored those associated with discharge, and also included routine treatment by insulin and statin as deleterious factors. CONCLUSIONS/INTERPRETATION: In patients with diabetes hospitalised for COVID-19, we established prognostic factors for hospital discharge and death that could help clinicians in this pandemic period. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT04324736.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba